FOXM1 Promotes Drug Resistance in Cervical Cancer Cells by Regulating ABCC5 Gene Transcription

por Hou, Youxiang, Dong, Zhanfei, Zhong, Wei, Yin, Linglong, Li, Xiong, Kuerban, Gulina, Huang, He
Publicado 2022

AKT1 regulates UHRF1 protein stability and promotes the resistance to abiraterone in prostate cancer

por Fu, Yongming, Cao, Tuoyu, Zou, Xiaorui, Ye, Yubing, Liu, Youhong, Peng, Yuchong, Deng, Tanggang, Yin, Linglong, Li, Xiong
Publicado 2023

FOXM1 promotes the progression of prostate cancer by regulating PSA gene transcription

por Liu, Youhong, Liu, Yijun, Yuan, Bowen, Yin, Linglong, Peng, Yuchong, Yu, Xiaohui, Zhou, Weibing, Gong, Zhicheng, Liu, Jianye, He, Leye, Li, Xiong
Publicado 2017

FOXM1 contributes to taxane resistance by regulating UHRF1-controlled cancer cell stemness

por Yuan, Bowen, Liu, Youhong, Yu, Xiaohui, Yin, Linglong, Peng, Yuchong, Gao, Yingxue, Zhu, Qianling, Cao, Tuoyu, Yang, Yinke, Fan, Xuegong, Li, Xiong
Publicado 2018

USP7 is a novel Deubiquitinase sustaining PLK1 protein stability and regulating chromosome alignment in mitosis

por Peng, Yuchong, Liu, Youhong, Gao, Yingxue, Yuan, Bowen, Qi, Xuli, Fu, Yuxin, Zhu, Qianling, Cao, Tuoyu, Zhang, Songwei, Yin, Linglong, Li, Xiong
Publicado 2019

PLK1 maintains DNA methylation and cell viability by regulating phosphorylation-dependent UHRF1 protein stability

por Peng, Yuchong, Liu, Youhong, Zheng, Rirong, Ye, Yubing, Fu, Yongming, Yin, Linglong, Gao, Yingxue, Fu, Yuxin, Qi, Xuli, Deng, Tanggang, Zhang, Songwei, Li, Xiong
Publicado 2023

AR antagonists develop drug resistance through TOMM20 autophagic degradation-promoted transformation to neuroendocrine prostate cancer

por Yin, Linglong, Ye, Yubing, Zou, Ling, Lin, Jinli, Dai, Yi, Fu, Yongming, Liu, Youhong, Peng, Yuchong, Gao, Yingxue, Fu, Yuxin, Qi, Xuli, Deng, Tanggang, Zhang, Songwei, Li, Xiong
Publicado 2023

PARP inhibitor veliparib and HDAC inhibitor SAHA synergistically co-target the UHRF1/BRCA1 DNA damage repair complex in prostate cancer cells

por Yin, Linglong, Liu, Youhong, Peng, Yuchong, Peng, Yongbo, Yu, Xiaohui, Gao, Yingxue, Yuan, Bowen, Zhu, Qianling, Cao, Tuoyu, He, Leye, Gong, Zhicheng, Sun, Lunquan, Fan, Xuegong, Li, Xiong
Publicado 2018

Correction to: PARP inhibitor veliparib and HDAC inhibitor SAHA synergistically co-target the UHRF1/. BRCA1 DNA damage repair complex in prostate cancer cells

por Yin, Linglong, Liu, Youhong, Peng, Yuchong, Peng, Yongbo, Yu, Xiaohui, Gao, Yingxue, Yuan, Bowen, Zhu, Qianling, Cao, Tuoyu, He, Leye, Gong, Zhicheng, Sun, Lunquan, Fan, Xuegong, Li, Xiong
Publicado 2022

Radiation-promoted CDC6 protein stability contributes to radioresistance by regulating senescence and epithelial to mesenchymal transition

por Yu, Xiaohui, Liu, Youhong, Yin, Linglong, Peng, Yongbo, Peng, Yuchong, Gao, Yingxue, Yuan, Bowen, Zhu, Qianling, Cao, Tuoyu, Xie, Bowen, Sun, Lunquan, Chen, Yan, Gong, Zhicheng, Qiu, Yuanzheng, Fan, Xuegong, Li, Xiong
Publicado 2018

The FOXM1–ABCC5 axis contributes to paclitaxel resistance in nasopharyngeal carcinoma cells

por Hou, Youxiang, Zhu, Qianling, Li, Zheng, Peng, Yongbo, Yu, Xiaohui, Yuan, Bowen, Liu, Yijun, Liu, Youhong, Yin, Linglong, Peng, Yuchong, Jiang, Zhenghua, Li, Jinping, Xie, Bowen, Duan, Yumei, Tan, Guolin, Gulina, Kurban, Gong, Zhicheng, Sun, Lunquan, Fan, Xuegong, Li, Xiong
Publicado 2017